Drug Pipeline

LP-005 Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
2
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-22 NCT07603713 Efficacy and Safety of LP-005 Injection in Patients With Moderate-to-Severe Periodontitis Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07212426 Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients. PNH - Paroxysmal Nocturnal Hemoglobinuria Active, Not Recruiting
NCT07363265 Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney… Complement-mediated Renal Diseases Not Yet Recruiting
NCT07603713 Efficacy and Safety of LP-005 Injection in Patients With Moderate-to-Severe Periodontitis Periodontitis Not Yet Recruiting
Sponsors Running LP-005 Injection Trials
Longbio Pharma (2) Longbio Pharma (Suzhou) Co., Ltd. (1)
Disease Areas
Chronic Kidney Disease (1)
Get alerts when LP-005 Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free